
Baxter is the master brand of Baxter International Inc. (NYSE: BAX), a medical products company headquartered in Deerfield, Illinois. The brand covers IV solutions, infusion pumps, pharmaceuticals, and connected care devices, a business generating approximately $11 billion in continuing operations revenue for fiscal year 2025.
Parent Company
Founded
1931
Status
Publicly Traded
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Baxter | Baxter International Inc. | Brand division |
Donald E. Baxter founded the company in 1931 in Illinois to mass-produce sterile IV solutions, essentially inventing the intravenous therapy supply industry that made modern medicine possible at scale.
The mid-century growth made Baxter the dominant US maker of IV systems and a healthcare institution, expanding into dialysis and hospital equipment through acquisitions including American Hospital Supply in 1985.
The 2015 Baxalta spin-off separated biopharma, and the 2021 Hillrom acquisition added connected care devices. The recent restructuring sold kidney care to Carlyle Group in January 2025, now independent as Vantive, and biopharma solutions in 2023, leaving a leaner company under Hider's new leadership.
What does Baxter own?
Post-divestiture it owns hospital products, pharmaceuticals, and connected care businesses including IV solutions, infusion systems, and the Hillrom device portfolio.
Is Baxter publicly traded?
Yes. It trades on the NYSE under ticker BAX and is an S&P 500 component.
Who founded Baxter?
Donald E. Baxter founded the company in 1931 in Illinois to mass-produce sterile IV solutions.
Where is Baxter headquartered?
The company is headquartered in Deerfield, Illinois, a Chicago suburb.
Who is the CEO of Baxter?
Andrew Hider became CEO in September 2025, succeeding interim CEO Brent Shafer, who became board chair. José Almeida retired in February 2025.
What happened to Baxter's kidney care business?
It was sold to Carlyle Group in January 2025 for $3.8 billion and now operates independently as Vantive.
What does Baxter sell?
IV solutions and systems, infusion pumps, pharmaceuticals including anesthesia, and connected care devices like smart beds and monitors.
IV supply crisis: Hurricane Helene's September 2024 damage to the North Cove plant caused a nationwide saline shortage, exposing critical supply chain concentration.
Product recalls: Periodic recalls on infusion pumps and devices occur through standard FDA processes, consistent with industry practice.
Restructuring disruption: The divestiture program and layoffs drew criticism over execution, though the strategic direction is now established.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Stryker | USA | 1971 | Market leader | United states | All Genders |
Market Positioning: Baxter competes with 1 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by Baxter International Inc., giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Kenvue
American adhesive bandage brand invented in 1921, owned by Kenvue Inc. Band-Aid is the leading adhesive bandage brand in the United States and is sold in more than 100 countries.
Band-Aid is privately owned, unlike Baxter which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Kenvue
American brand of antihistamine medication used to treat allergies, itching, and cold symptoms, manufactured and marketed by Johnson & Johnson.
Benadryl is privately owned, unlike Baxter which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Boots is the UK's leading pharmacy-led health and beauty retailer, founded in 1849, now operating as The Boots Group under Sycamore Partners since August 2025.
Boots is privately owned, unlike Baxter which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Duane Reade is a New York City drugstore chain owned by Walgreen Co. under Sycamore Partners, operating approximately 90 stores across the five boroughs.
Duane Reade is privately owned, unlike Baxter which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Kenvue
American brand of ibuprofen pain relief medication owned by Kenvue, the consumer health spinoff from Johnson & Johnson, which is being acquired by Kimberly-Clark in a $40 billion deal announced in November 2025.
Motrin is privately owned, unlike Baxter which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Kenvue
American brand of over-the-counter first aid antibiotic ointment containing bacitracin, neomycin, and polymyxin B. Owned by Kenvue (NYSE: KVUE) since the August 2023 spin-off from Johnson & Johnson.
Neosporin is privately owned, unlike Baxter which is under a publicly traded parent company.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.

Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.